Vitaspring Biomedical VSBC
OTC VSBC
$0.02 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Vitaspring Biomedical (VSBC) Long-Term Deferred Tax (2021)

Updated

Vitaspring Biomedical (VSBC) recorded Long-Term Deferred Tax of $30,595 in fiscal Q3 2022 (quarter ended Oct 31, 2021).

Analysis

Vitaspring Biomedical (VSBC) Long-Term Deferred Tax (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Vitaspring Biomedical 4.14 Mn 4.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2021 30,595.00
API Access

Vitaspring Biomedical Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=VSBC&period=max&api_key=YOUR_API_KEY